Bristol-Myers Squibb Foundation and Corporate Philanthropy

+10.31.2008 Bristol-Myers Squibb Foundation to Award $1.4 Million in Grants to Bridge Gaps in Hepatitis C Awareness, Prevention and Care in Asia +10.02.2008 BIPAI Opens New Children's AIDS Center in Uganda +12.05.2007 Governor Riley Announces Grant to Improve Mental Health Services in the Black Belt

Foundation Staff

Foundation Board of Directors

James M. Cornelius, Chairman
Lamberto Andreotti
John E. Celentano
John L. Damonti
Brian Daniels, M.D.
Anthony C. Hooper
Sandra Leung
Anthony McBride, Ph.D.
Elliott Sigal, M.D., Ph.D.
Richard L. Thompson
Robert T. Zito

Foundation Staff

John L. Damonti, President
Patricia Doykos, Ph.D.
S. Anders Hedberg, Ph.D.
Cindy Johnson
Mariam Kassambara-Sow, M.D.
Meredith Lamendola
Beryl Mohr
Phangisile Mtshali
Christine Newman
Vivienne Stewart-Seaton
Fode Traore
Damon Young
Lilibeth Zandueta

[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.